Immune-Onc Therapeutics Company
![](/storage/logos_100px/Immune-Onc Therapeutics.jpg)
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Palo Alto, California, United States
Founded Date:
2016
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership